1/11
222 files

Quadruple immunofluoresence images of skeletal muscle biopsies from patients with the mtDNA m.3243A>G variant

dataset
posted on 29.04.2022, 07:19 authored by Syeda Tasnim Ahmed, Doug Turnbull, Robert Taylor, Conor LawlessConor Lawless, Sarah PickettSarah Pickett

Fluorescent images of 10µm transverse muscle sections from patients carrying the pathogenic m.3243A>G mtDNA variant, captured by automated scanning at 20× magnification using Zen 2011 (blue edition) software and Zeiss Axio imager MI microscope. Exposure times across all sections for each experimental batch were maintained.


Muscle sections were stained using a 'Quantitative quadruple immunohistochemistry' technique, designed to capture expression profiles of proteins belonging to oxidative phosphorylation (OXPHOS) complexes. 'OXPHOS' sections were labelled with antibodies detecting subunits of mitochondrial complex I (NDUFB8) and complex IV (COX-1), a mitochondrial mass marker (mitochondrial porin; VDAC1) and laminin, followed by incubation with secondary antibodies (Alexa Fluor 488, 546, biotinylated IgG1 and 750) and subsequently with streptavidin 647. Alongside each sample, a no-primary control section (NPC; labelled only for laminin) was processed.


This resource contains .iaf, .jpg and .png files from OXPHOS and NPC sections from 17 patients (P01-P17) and five controls (C01-C05). It also contains PDFs for 10 sections for which single fibre molecular genetic data are available at https://github.com/CnrLwlss/Ahmed_2022


File naming convention:


b : where n=2 or 3 and refers to the batch that the samples were processed in. 

P01-P17 : Sections from m.3243A>G patients

C01-C05 : Non-disease controls

NPC : Non-primary control - sections labelled only with laminin

OXPHOS : Sections labelled for OXPHOS complexes

ch1 : MTCO1 (Complex IV; 488nm)

ch2 : VDAC (Porin; 546nm)

ch3 : NDUFB8 (Complex I; 647nm)

ch4 : Laminin (750nm)






Funding

Wellcome Centre for Mitochondrial Research

Wellcome Trust

Find out more...

Identification of nuclear factors modulating the clinical phenotype of m.3243A>G-related mitochondrial disease.

Wellcome Trust

Find out more...

MRC Strategic Award to establish an International Centre for Genomic Medicine in Neuromuscular Diseases

Medical Research Council

Find out more...

History

UoA

Clinical Medicine